JOHNSON & JOHNSON

Hartford Equity Income Fund (I Share) outperformed the Russell 1000 Value Index during the quarter. Read more here.

The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.

The fund outperformed the Russell 1000 Value Index due to strong stock selection in several sectors, despite underperformance in information technology, materials and financials.

Shares of Kenvue rose in early Thursday trading after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates.

NEW BRUNSWICK, N.J., May 08, 2025--Johnson & Johnson today announced the expansion of its efforts to champion the nursing workforce and improve access to quality care for communities around the world. These efforts are part of J&J CareCommunity, a new social impact platform that focuses the resources and expertise of J&J and J&J Foundation to support nurses at every step of their career journey and strengthen health systems worldwide. The expansion aims to help address the global shortfall of nu

In an environment characterized by high uncertainty, we believe investors will place greater emphasis on companies with stable dividends.

BeiGene's innovative cancer treatments, Brukinsa and Tevimbra, are driving growth. Click for a look at ONC and its latest earnings results.

Franklin Equity Income Fund's Q1 2025 report provides insights into market trends, fund performance, key sector contributions, and outlook. Click here to read more.

The Franklin Small Cap Growth Fund underperformed its Russell 2000 Growth Index benchmark in the first quarter of 2025. Click here to read the full commentary.

Over the first quarter of 2025, Franklin Global Allocation Fund proved more resilient than its benchmark. Click here to read the full commentary.